Shortness of breath: An uncommon side-effect of cyproterone acetate in the treatment of androgenetic alopecia

International Journal of Dermatology

Volumn 41, Issue 12, 2002, Pages 946-947

  Mallari, Rica ^a   Sinclair, Rodney D ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE;

AGED; CASE REPORT; CONFERENCE PAPER; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG RECHALLENGE; DRUG WITHDRAWAL; DYSPNEA; EXERCISE; FEMALE; HAIR LOSS; HUMAN; MALE TYPE ALOPECIA; POSTMENOPAUSE; RECURRENT DISEASE; REST; SKIN BIOPSY; VIRILIZATION;

AGED; ALOPECIA; ANDROGEN ANTAGONISTS; CYPROTERONE ACETATE; DYSPNEA; FEMALE; HUMANS;

EID: 0036942520     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01581.x     Document Type: Article

References (4)

1. Dollery C (ed). Cyproterone (acetate). In: Therapeutic Drugs. 2nd edn, vol. 1. Edinburgh: Churchill Livingstone, 1999: C370-73.
2. Callan A, Montalto J. Female androgenetic alopecia. Aust J Dermatol 1995; 36: 51-57.
3. Tran D, Sinclair RD. Understanding and managing common baldness. Aust Fam Physician 1999; 28: 248-253.
4. Green N, Harrison B. Breathlessness in patients with prostatic carcinoma treated with cyproterone acetate. Br Med J 1989; 298: 1524.